-
公开(公告)号:US20120108567A1
公开(公告)日:2012-05-03
申请号:US13347797
申请日:2012-01-11
申请人: Darryl McCONNELL , Maria IMPAGNATIELLO , Dirk KESSLER , Oliver KRAEMER , Siegfried SCHNEIDER , Lars VAN DER VEEN , Ulrike WEYER-CZERNILOFSKY , Tobias WUNBERG
发明人: Darryl McCONNELL , Maria IMPAGNATIELLO , Dirk KESSLER , Oliver KRAEMER , Siegfried SCHNEIDER , Lars VAN DER VEEN , Ulrike WEYER-CZERNILOFSKY , Tobias WUNBERG
IPC分类号: A61K31/4439 , A61K31/5377 , A61P35/00 , A61K31/4709 , A61K31/496 , C07D513/04 , A61K31/4545
CPC分类号: C07D513/04
摘要: The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要翻译: 本发明包括通式(1)的化合物,其中R 1至R 3如权利要求1中所定义,其适用于治疗以细胞增殖过度或异常为特征的疾病,以及其用于制备具有上述特征的药物的用途, 上述属性。
-
公开(公告)号:US20110112087A1
公开(公告)日:2011-05-12
申请号:US12763537
申请日:2010-04-20
申请人: Lars VAN DER VEEN , Maria Impagnatiello , Darryl McConnell , Siegfried Schneider , Tobias Wunberg
发明人: Lars VAN DER VEEN , Maria Impagnatiello , Darryl McConnell , Siegfried Schneider , Tobias Wunberg
IPC分类号: A61K31/5377 , C07D513/04 , A61K31/4439 , A61P35/00 , A61K31/4545 , A61K31/429
CPC分类号: C07D513/04
摘要: The present invention encompasses compounds of general formula (1) whereinR1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要翻译: 本发明包括通式(1)的化合物,其中R 1至R 3和X如权利要求1中所定义,其适用于治疗以细胞增殖过度或异常为特征的疾病,以及其用于制备具有 上述属性。
-
公开(公告)号:US20130196975A1
公开(公告)日:2013-08-01
申请号:US13795722
申请日:2013-03-12
IPC分类号: C07D213/73 , C07D487/08 , C07D413/14 , C07D471/04 , C07D405/14 , C07D401/14
CPC分类号: C07D213/73 , C07D401/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D487/08
摘要: The present invention encompasses compounds of general formula (1) wherein R1 to R4, m and n are defined as in the specification, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
摘要翻译: 本发明包括通式(1)的化合物,其中R 1至R 4,m和n如本说明书所定义,其适用于治疗以细胞增殖过度或异常为特征的疾病及其用于制备药物的用途 具有上述性质。
-
-